NHWK - NightHawk Biosciences, Inc. Stock Price, Fair Value and News

$0.16

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

NHWK Price Action

Last 30 days

-48.4%

Last 90 days

-64.4%

NHWK RSI Chart

NHWK Valuation

Market Cap

693.0K

Price/Earnings (Trailing)

-0.02

Price/Sales (Trailing)

0.07

EV/EBITDA

0.17

Price/Free Cashflow

-0.03

NHWK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NHWK Fundamentals

NHWK Revenue

Revenue (TTM)

10.0M

Rev. Growth (Yr)

27.55%

Rev. Growth (Qtr)

21.37%

NHWK Earnings

Earnings (TTM)

-28.8M

Earnings Growth (Yr)

22.98%

Earnings Growth (Qtr)

-13.96%

NHWK Profitability

EBT Margin

-308.57%

Return on Equity

-100.3%

Return on Assets

-61.92%

Free Cashflow Yield

-3.3K%

NHWK Investor Care

Buy Backs (1Y)

83.39%

Diluted EPS (TTM)

226.66

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	9.7M	9.8M	10.0M	0
2023	939.7K	1.5M	2.2M	7.0M
2022	1.8M	1.4M	935.4K	386.2K
2021	2.6M	2.5M	2.1M	2.1M
2020	3.2M	3.5M	4.3M	2.9M
2019	5.7M	4.9M	3.1M	3.0M
2018	2.6M	3.7M	4.7M	5.8M
2017	538.0K	734.4K	1.1M	1.3M
2016	43.3K	142.7K	242.2K	341.6K
2015	38.7K	0	0	0
2014	17.7K	25.3K	32.9K	40.6K
2013	0	0	0	10.1K
2012	0	0	0	3.1K

Get all data in R, Python etc through our Historical Stock Data APIs

About NightHawk Biosciences, Inc.

NightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM (obiltoxaximab), a monoclonal antibody antitoxin for the treatment of inhalational anthrax. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

CEO	Mr. Jeffrey Alan Wolf J.D.
WEBSITE	nighthawkbio.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	77

NightHawk Biosciences, Inc. Frequently Asked Questions

What is the ticker symbol for NightHawk Biosciences, Inc.? What does NHWK stand for in stocks?

NHWK is the stock ticker symbol of NightHawk Biosciences, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of NightHawk Biosciences, Inc. (NHWK)?

As of Thu Oct 31 2024, market cap of NightHawk Biosciences, Inc. is 693 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NHWK stock?

You can check NHWK's fair value in chart for subscribers.

Is NightHawk Biosciences, Inc. a good stock to buy?

The fair value guage provides a quick view whether NHWK is over valued or under valued. Whether NightHawk Biosciences, Inc. is cheap or expensive depends on the assumptions which impact NightHawk Biosciences, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NHWK.

What is NightHawk Biosciences, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Oct 31 2024, NHWK's PE ratio (Price to Earnings) is -0.02 and Price to Sales (PS) ratio is 0.07. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NHWK PE ratio will change depending on the future growth rate expectations of investors.